Nishiwaki S - Search Results

1

Binding competition of okadaic acid derivatives to anti-okadaic acid antibody.

Yatsunami J, Fujiki H, Suganuma M, Nishiwaki S, Ojika M, Yamada K, Levine L. Yatsunami J, et al. Among authors: nishiwaki s. Toxicon. 1991;29(11):1409-12. doi: 10.1016/0041-0101(91)90129-f. Toxicon. 1991. PMID: 1814017

2

Structurally different members of the okadaic acid class selectively inhibit protein serine/threonine but not tyrosine phosphatase activity.

Suganuma M, Fujiki H, Okabe S, Nishiwaki S, Brautigan D, Ingebritsen TS, Rosner MR. Suganuma M, et al. Among authors: nishiwaki s. Toxicon. 1992 Aug;30(8):873-8. doi: 10.1016/0041-0101(92)90385-i. Toxicon. 1992. PMID: 1326138

3

Specific mechanistic aspects of animal tumor promoters: the okadaic acid pathway.

Fujiki H, Suganuma M, Nishiwaki S, Yoshizawa S, Yatsunami J, Matsushima R, Furuya H, Okabe S, Matsunaga S, Sugimura T. Fujiki H, et al. Among authors: nishiwaki s. Prog Clin Biol Res. 1992;374:337-50. Prog Clin Biol Res. 1992. PMID: 1620710 Review. No abstract available.

4

Mechanisms of action of okadaic acid class tumor promoters on mouse skin.

Fujiki H, Suganuma M, Yoshizawa S, Nishiwaki S, Winyar B, Sugimura T. Fujiki H, et al. Among authors: nishiwaki s. Environ Health Perspect. 1991 Jun;93:211-4. doi: 10.1289/ehp.9193211. Environ Health Perspect. 1991. PMID: 1663450 Free PMC article.

5

Photoaffinity labeling of protein phosphatase 2A, the receptor for a tumor promoter okadaic acid, by [27-3H]methyl 7-O-(4-azidobenzoyl)okadaate.

Nishiwaki S, Fujiki H, Suganuma M, Ojika M, Yamada K, Sugimura T. Nishiwaki S, et al. Biochem Biophys Res Commun. 1990 Aug 16;170(3):1359-64. doi: 10.1016/0006-291x(90)90544-w. Biochem Biophys Res Commun. 1990. PMID: 2167675

6

A new pathway of tumor promotion by the okadaic acid class compounds.

Fujiki H, Suganuma M, Nishiwaki S, Yoshizawa S, Winyar B, Sugimura T, Schmitz FJ. Fujiki H, et al. Among authors: nishiwaki s. Adv Second Messenger Phosphoprotein Res. 1990;24:340-4. Adv Second Messenger Phosphoprotein Res. 1990. PMID: 2169814 No abstract available.

7

Structure-activity relationship within a series of okadaic acid derivatives.

Nishiwaki S, Fujiki H, Suganuma M, Furuya-Suguri H, Matsushima R, Iida Y, Ojika M, Yamada K, Uemura D, Yasumoto T, et al. Nishiwaki S, et al. Carcinogenesis. 1990 Oct;11(10):1837-41. doi: 10.1093/carcin/11.10.1837. Carcinogenesis. 1990. PMID: 2170047

8

Marine natural products against tumor development.

Yatsunami J, Fujiki H, Komori A, Suganuma M, Nishiwaki S, Okabe S, Nishiwaki-Matsushima R, Ohta T, Matsunaga S, Fusetani N, et al. Yatsunami J, et al. Among authors: nishiwaki s, nishiwaki matsushima r. J Nutr Sci Vitaminol (Tokyo). 1992;Spec No:333-6. doi: 10.3177/jnsv.38.special_333. J Nutr Sci Vitaminol (Tokyo). 1992. PMID: 1297766

9

Anticarcinogenic effects of (-)-epigallocatechin gallate.

Fujiki H, Yoshizawa S, Horiuchi T, Suganuma M, Yatsunami J, Nishiwaki S, Okabe S, Nishiwaki-Matsushima R, Okuda T, Sugimura T. Fujiki H, et al. Among authors: nishiwaki s, nishiwaki matsushima r. Prev Med. 1992 Jul;21(4):503-9. doi: 10.1016/0091-7435(92)90057-o. Prev Med. 1992. PMID: 1409491 Review.

10

Differential effects of cryptoporic acids D and E, inhibitors of superoxide anion radical release, on tumor promotion of okadaic acid in mouse skin.

Matsunaga S, Furuya-Suguri H, Nishiwaki S, Yoshizawa S, Suganuma M, Hashimoto T, Asakawa Y, Fujiki H. Matsunaga S, et al. Among authors: nishiwaki s. Carcinogenesis. 1991 Jun;12(6):1129-31. doi: 10.1093/carcin/12.6.1129. Carcinogenesis. 1991. PMID: 1646082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters